Document is current
Any future updates will be listed below
-
Authors
Lowe, Patrick P.
Morel, Caroline
Ambade, Aditya
Iracheta-Vellve, Arvin
Kwiatkowski, Erica
Satishchandran, Abhishek
Furi, Istvan
Cho, Yeonhee
Gyongyosi, Benedek
Catalano, Donna
Lefebvre, Eric
Fischer, Laurent
Seyedkazemi, Star
Schafer, Dorothy P.
Szabo, Gyongyi https://orcid.org/0000-0003-0836-2527
-
Funding
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (F30AA024680, 5R01AA017729-05)
Allergan Foundation
- License Information
-
More Information
Article History
Received: 8 May 2020
Accepted: 30 September 2020
First Online: 9 October 2020
Ethics approval and consent to participate
: All animal studies were approved by the Institutional Animal Care and Use Committee at the University of Massachusetts Medical School (UMMS). All the methods were carried out in accordance with the approved guidelines.
: Not applicable.
: Dr. Szabo consults for Allergan, Alnylam, Arrow, Durcect Corporation, Generon, Glympse Bio, Terra Firma, Quest Diagnostsics, Pandion Therapeutics, Surrozen, and Zomagen. She has received grants from Gilead, Genfit, Intercept, Novartis, SignaBlok, and Shire. She holds intellectual property rights with Up to Date. The co-authors declare no competing financial interests.
